ADAMIS PHARMACEUTICALS CORP (ADMP)
US00547W3079 - Common Stock
Adamis changes name to DMK Pharmaceuticals, ticker to DMK (NASDAQ:ADMP)
Adamis Pharmaceuticals (ADMP) is changing its name to DMK Pharmaceuticals (DMK) and its Nasdaq ticker symbol to DMK. Read more here.
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
Company to begin trading under new ticker symbol “DMK” on September 8, 2023...
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...
FVRR, CHRS and NVBSE are among pre market gainers (NASDAQ:ADMP)
Traeger (COOK) +28%. NeuBase Therapeutics (NBSE) +21%
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday morning!
Adamis Pharmaceuticals down after announcing pricing of $8M public offering (NASDAQ:ADMP)
Adamis Pharmaceuticals Corporation (ADMP) shares down 71% after it announced pricing of its public offering of 5,930,000 units at a price of $1.35 per unit.Each unit consists of one...
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the latest news for Wednesday!
Adamis stock soars as high as 480% amid asset sale, drug study news (NASDAQ:ADMP)
Adamis (ADMP) stock rocketed Tuesday following news that it had sold certain assets and was funding additional research for its opioid overdose drug ZIMHI. Read more here.
Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...
Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use Disorder
SAN DIEGO, June 26, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...
Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention
SAN DIEGO, June 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined companyCombined company will have commercial products and a library of...
Adamis Pharma stock on reverse stock slip (NASDAQ:ADMP)
Adamis Pharmaceuticals (ADMP) fell ~19% Friday after announcing plans to effect a 1-for-70 reverse stock split of its common stock from next week. Read more here.